Latest News about TEVA
Recent news which mentions TEVA
Tesla, Avinger, Jet.Ai, Teva, And Netflix: Why These 5 Stocks Are On Investors' Radars Ahead Of Christmas
December 24, 2024
From Benzinga
Stanley Druckenmiller Dumps Street's Hottest AI Stocks — Here's What The Billionaire Investor Is Betting On Next
December 24, 2024
From Benzinga
Billionaire Stanley Druckenmiller Is Selling Nvidia and Palantir and Piling Into One of Wall Street's Hottest Drug Stocks Ahead of 2025
December 24, 2024
From Motley Fool
Big Biopharma Trails Behind The Market: JP Morgan's 2025 Outlook on Eli Lilly, Merck, and More
December 22, 2024
From Benzinga
Teva Pharmaceutical, Li Auto, And Darden Restaurants Are Among Top Large Cap Gainers Last Week (December 16-20): Are The Others In Your Portfolio?
December 22, 2024
From Benzinga
My Top 10 Portfolio Holdings for 2025
December 20, 2024
From Motley Fool
Teva Pharmaceutical Releases Impressive Phase 2 Candidate Data For Gastro-Related Diseases
December 18, 2024
From Benzinga
Nukkleus, Micron, Teva Pharmaceutical, Quantum Computing, Tesla: Why These 5 Stocks Are On Investors' Radars Today
December 17, 2024
From Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
December 17, 2024
From Benzinga
RCI Hospitality, Quantum Computing, Teva Pharmaceutical, Tesla And Other Big Stocks Moving Higher On Monday
December 17, 2024
From Benzinga
Why Are Teva And Sanofi Stocks Trading Higher On Tuesday?
December 17, 2024
From Benzinga
9 Health Care Stocks With Whale Alerts In Today's Session
December 16, 2024
From Benzinga
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
December 11, 2024
From Benzinga
Is SoundHound AI a Millionaire-Maker Stock?
December 03, 2024
From Motley Fool
Plant-Based API Market Poised To Hit $52 Billion By 2034, Driven By Psychedelics And Cannabinoids
November 15, 2024
From Benzinga
Teva Pharmaceutical Industries (TEVA) Q3 2024 Earnings Call Transcript
November 06, 2024
Tickers
TEVA
From Motley Fool
From Benzinga
From Benzinga
Amicus Therapeutics Settles Patent Lawsuit Teva Pharmaceuticals Over Generic Version Of Its Rare Genetic Disorder Drug
October 17, 2024
From Benzinga
Teva Pays $450M To Resolve Alleged Kickback, Price-Fixing Schemes
October 11, 2024
From Benzinga
Here's How Much $100 Invested In Teva Pharmaceutical Indus 5 Years Ago Would Be Worth Today
October 10, 2024
From Benzinga
Medicare Drug Price Negotiation Program Gets Final Guidance For Second Cycle, $1.5B Savings Expected
October 03, 2024
From Benzinga
Teva Launches Generic Version Of Sandostatin In The US
October 01, 2024
From Benzinga
$1000 Invested In Teva Pharmaceutical Indus 5 Years Ago Would Be Worth This Much Today
September 30, 2024
From Benzinga
Corcept Therapeutics' Commercial Drug Korlym Sales Impress Despite Increased Competition, Analyst Boosts Price Forecast
September 30, 2024
From Benzinga
If You Invested $1000 In This Stock 5 Years Ago, You Would Have $2,400 Today
September 16, 2024
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.